

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.17240142 |
| 2 | plasma membrane repair (GO:0001778) | 8.29170523 |
| 3 | actin filament-based movement (GO:0030048) | 7.81173748 |
| 4 | skeletal muscle fiber development (GO:0048741) | 7.35713228 |
| 5 | sarcomere organization (GO:0045214) | 7.08679487 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.97189440 |
| 7 | striated muscle contraction (GO:0006941) | 6.74317965 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.53664621 |
| 9 | myofibril assembly (GO:0030239) | 6.32163596 |
| 10 | myotube cell development (GO:0014904) | 6.28783692 |
| 11 | creatine metabolic process (GO:0006600) | 6.28383775 |
| 12 | glycogen catabolic process (GO:0005980) | 6.04968273 |
| 13 | skeletal muscle tissue regeneration (GO:0043403) | 6.00596446 |
| 14 | carnitine shuttle (GO:0006853) | 5.91843593 |
| 15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.79584293 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 5.78087733 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.77923510 |
| 18 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.73144107 |
| 19 | glucan catabolic process (GO:0009251) | 5.66197045 |
| 20 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.63505173 |
| 21 | striated muscle atrophy (GO:0014891) | 5.61945170 |
| 22 | cytidine catabolic process (GO:0006216) | 5.60971353 |
| 23 | cytidine deamination (GO:0009972) | 5.60971353 |
| 24 | cytidine metabolic process (GO:0046087) | 5.60971353 |
| 25 | response to muscle activity (GO:0014850) | 5.44832511 |
| 26 | * muscle contraction (GO:0006936) | 5.44736699 |
| 27 | response to inactivity (GO:0014854) | 5.36123057 |
| 28 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.32120055 |
| 29 | cellular polysaccharide catabolic process (GO:0044247) | 5.26816942 |
| 30 | striated muscle adaptation (GO:0014888) | 5.06435120 |
| 31 | polysaccharide catabolic process (GO:0000272) | 5.02523100 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 5.02108329 |
| 33 | purine nucleotide salvage (GO:0032261) | 5.00542785 |
| 34 | actomyosin structure organization (GO:0031032) | 4.90214714 |
| 35 | muscle atrophy (GO:0014889) | 4.87219478 |
| 36 | glucan biosynthetic process (GO:0009250) | 4.87194263 |
| 37 | glycogen biosynthetic process (GO:0005978) | 4.87194263 |
| 38 | * muscle system process (GO:0003012) | 4.85628228 |
| 39 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.85121971 |
| 40 | NADH metabolic process (GO:0006734) | 4.84233942 |
| 41 | muscle fiber development (GO:0048747) | 4.82295888 |
| 42 | regulation of relaxation of muscle (GO:1901077) | 4.79646437 |
| 43 | cardiac muscle hypertrophy (GO:0003300) | 4.78154029 |
| 44 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.46452319 |
| 45 | carnitine transmembrane transport (GO:1902603) | 4.38538130 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 4.38134676 |
| 47 | regulation of coenzyme metabolic process (GO:0051196) | 4.38134676 |
| 48 | cardiac muscle contraction (GO:0060048) | 4.37984438 |
| 49 | IMP metabolic process (GO:0046040) | 4.34299488 |
| 50 | tricarboxylic acid cycle (GO:0006099) | 4.27119349 |
| 51 | fructose metabolic process (GO:0006000) | 4.21999036 |
| 52 | glycogen metabolic process (GO:0005977) | 4.19735218 |
| 53 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.19503922 |
| 54 | muscle cell fate commitment (GO:0042693) | 4.13764037 |
| 55 | muscle adaptation (GO:0043500) | 4.12698670 |
| 56 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.11772298 |
| 57 | cellular glucan metabolic process (GO:0006073) | 4.11273114 |
| 58 | glucan metabolic process (GO:0044042) | 4.11273114 |
| 59 | cardiac myofibril assembly (GO:0055003) | 4.10724798 |
| 60 | muscle hypertrophy (GO:0014896) | 4.07511825 |
| 61 | carnitine transport (GO:0015879) | 4.00175537 |
| 62 | amino-acid betaine transport (GO:0015838) | 4.00175537 |
| 63 | muscle organ morphogenesis (GO:0048644) | 3.95330518 |
| 64 | negative regulation of muscle hypertrophy (GO:0014741) | 3.92110641 |
| 65 | muscle tissue morphogenesis (GO:0060415) | 3.92016583 |
| 66 | myoblast fusion (GO:0007520) | 3.89843832 |
| 67 | gluconeogenesis (GO:0006094) | 3.88519349 |
| 68 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.83968022 |
| 69 | striated muscle cell development (GO:0055002) | 3.83357769 |
| 70 | response to activity (GO:0014823) | 3.83071179 |
| 71 | muscle organ development (GO:0007517) | 3.78298323 |
| 72 | adult heart development (GO:0007512) | 3.78054280 |
| 73 | muscle structure development (GO:0061061) | 3.74084393 |
| 74 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.72845849 |
| 75 | muscle cell cellular homeostasis (GO:0046716) | 3.72469547 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.67991777 |
| 77 | heart contraction (GO:0060047) | 3.66387087 |
| 78 | heart process (GO:0003015) | 3.66387087 |
| 79 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.61267797 |
| 80 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.61267797 |
| 81 | regulation of actin filament-based movement (GO:1903115) | 3.61208281 |
| 82 | regulation of sulfur metabolic process (GO:0042762) | 3.57961152 |
| 83 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.57512437 |
| 84 | cellular response to dexamethasone stimulus (GO:0071549) | 3.54841792 |
| 85 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.54821885 |
| 86 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.54821885 |
| 87 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.52844148 |
| 88 | regulation of striated muscle contraction (GO:0006942) | 3.52666320 |
| 89 | negative regulation of muscle contraction (GO:0045932) | 3.50241236 |
| 90 | cardiac muscle cell development (GO:0055013) | 3.49644134 |
| 91 | hexose biosynthetic process (GO:0019319) | 3.47741387 |
| 92 | skeletal muscle tissue development (GO:0007519) | 3.44125990 |
| 93 | positive regulation of myoblast differentiation (GO:0045663) | 3.44048010 |
| 94 | striated muscle tissue development (GO:0014706) | 3.43249905 |
| 95 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.41052693 |
| 96 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.40588482 |
| 97 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.39850175 |
| 98 | muscle hypertrophy in response to stress (GO:0003299) | 3.39850175 |
| 99 | cardiac muscle adaptation (GO:0014887) | 3.39850175 |
| 100 | myotube differentiation (GO:0014902) | 3.39683549 |
| 101 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.38522192 |
| 102 | ubiquinone biosynthetic process (GO:0006744) | 3.36710328 |
| 103 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.35603183 |
| 104 | neuronal action potential propagation (GO:0019227) | 3.32834470 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.32258984 |
| 106 | cellular carbohydrate catabolic process (GO:0044275) | 3.31100307 |
| 107 | positive regulation of myotube differentiation (GO:0010831) | 3.30979788 |
| 108 | response to dexamethasone (GO:0071548) | 3.30124095 |
| 109 | relaxation of muscle (GO:0090075) | 3.30022534 |
| 110 | IMP biosynthetic process (GO:0006188) | 3.27865489 |
| 111 | muscle cell development (GO:0055001) | 3.26176071 |
| 112 | cardiac cell development (GO:0055006) | 3.25775955 |
| 113 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.24224955 |
| 114 | neuromuscular synaptic transmission (GO:0007274) | 3.15936084 |
| 115 | regulation of membrane repolarization (GO:0060306) | 3.13840998 |
| 116 | 2-oxoglutarate metabolic process (GO:0006103) | 3.06757352 |
| 117 | striated muscle hypertrophy (GO:0014897) | 3.04209144 |
| 118 | regulation of sequestering of triglyceride (GO:0010889) | 3.02581291 |
| 119 | regulation of myoblast differentiation (GO:0045661) | 3.00902946 |
| 120 | muscle filament sliding (GO:0030049) | 12.7566623 |
| 121 | actin-myosin filament sliding (GO:0033275) | 12.7566623 |
| 122 | regulation of skeletal muscle contraction (GO:0014819) | 11.5935981 |
| 123 | skeletal muscle contraction (GO:0003009) | 10.7430205 |
| 124 | actin-mediated cell contraction (GO:0070252) | 10.4634936 |
| 125 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.3613910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.62339281 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.94418256 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.64668673 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.55467956 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.17151521 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.13611096 |
| 7 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.85036586 |
| 8 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.85036586 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.71883257 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.51404149 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.50363357 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39125812 |
| 13 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.33418061 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.25748716 |
| 15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.07327584 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.99122990 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.88763059 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81716850 |
| 19 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.78746904 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.73395369 |
| 21 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.70834491 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68791115 |
| 23 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.67390246 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67380127 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65763901 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65404969 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.64087624 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.63114960 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.59911902 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53565199 |
| 31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.53090394 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51548609 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49885216 |
| 34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.47449379 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40580239 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37556249 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37264832 |
| 38 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33329278 |
| 39 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.32896594 |
| 40 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.32876585 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31842145 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29846711 |
| 43 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28262663 |
| 44 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28141403 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24820962 |
| 46 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.23610354 |
| 47 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.20203883 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.19417496 |
| 49 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18520608 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17341826 |
| 51 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.14755202 |
| 52 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14280048 |
| 53 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.12844927 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12659535 |
| 55 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.11445628 |
| 56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10950247 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10111816 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09866474 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09439884 |
| 60 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07545830 |
| 61 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.07036315 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07001552 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05999100 |
| 64 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.05610461 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04554450 |
| 66 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.04241909 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04225575 |
| 68 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04225575 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02942076 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00948377 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00702679 |
| 72 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00646243 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00493616 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.99542685 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99473025 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97688516 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97621295 |
| 78 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96887854 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96676889 |
| 80 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96436318 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96045389 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95745752 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95622543 |
| 84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95591056 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95232702 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94556932 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94466022 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93943401 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.93855332 |
| 90 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93767356 |
| 91 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92787371 |
| 92 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.91921542 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90873613 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90517949 |
| 95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90203948 |
| 96 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.89838834 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88836360 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88836360 |
| 99 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.88629974 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88507145 |
| 101 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86864782 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86788845 |
| 103 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86660316 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86095984 |
| 105 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86001730 |
| 106 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85713067 |
| 107 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.85666506 |
| 108 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85049395 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84724669 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84696913 |
| 111 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84648895 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84228233 |
| 113 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84141194 |
| 114 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83428487 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82882885 |
| 116 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82764672 |
| 117 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.82649013 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82584351 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82569158 |
| 120 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82420210 |
| 121 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.82071767 |
| 122 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81830746 |
| 123 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81652184 |
| 124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81453935 |
| 125 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81421051 |
| 126 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80855056 |
| 127 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.80853994 |
| 128 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.80604849 |
| 129 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80160943 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79811638 |
| 131 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78400989 |
| 132 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.76161259 |
| 133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74439981 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.73929986 |
| 135 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71862067 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.71734669 |
| 137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.71734669 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70475509 |
| 139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69663831 |
| 140 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.69117320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.34979442 |
| 2 | MP0003646_muscle_fatigue | 6.57367495 |
| 3 | MP0000749_muscle_degeneration | 6.22337847 |
| 4 | MP0000751_myopathy | 5.84497372 |
| 5 | MP0000747_muscle_weakness | 4.29945453 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 4.11970275 |
| 7 | MP0002106_abnormal_muscle_physiology | 4.11479855 |
| 8 | MP0004036_abnormal_muscle_relaxation | 4.07917463 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.68386089 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.50544802 |
| 11 | MP0002269_muscular_atrophy | 3.46949146 |
| 12 | MP0005369_muscle_phenotype | 3.43061634 |
| 13 | MP0004130_abnormal_muscle_cell | 3.33527672 |
| 14 | MP0000750_abnormal_muscle_regeneration | 3.26516030 |
| 15 | MP0005620_abnormal_muscle_contractility | 3.12540947 |
| 16 | MP0004233_abnormal_muscle_weight | 2.58203457 |
| 17 | MP0005330_cardiomyopathy | 2.33176406 |
| 18 | MP0004084_abnormal_cardiac_muscle | 2.27621006 |
| 19 | MP0000733_abnormal_muscle_development | 2.25538975 |
| 20 | MP0002332_abnormal_exercise_endurance | 2.15916063 |
| 21 | MP0002108_abnormal_muscle_morphology | 1.97055839 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 1.96705806 |
| 23 | MP0004215_abnormal_myocardial_fiber | 1.92009957 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.67542645 |
| 25 | MP0004484_altered_response_of | 1.63248185 |
| 26 | MP0002972_abnormal_cardiac_muscle | 1.62724126 |
| 27 | MP0005666_abnormal_adipose_tissue | 1.52142984 |
| 28 | MP0010630_abnormal_cardiac_muscle | 1.44038463 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37171678 |
| 30 | MP0002971_abnormal_brown_adipose | 1.35112902 |
| 31 | MP0004270_analgesia | 1.21461916 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.18729224 |
| 33 | MP0005385_cardiovascular_system_phenoty | 1.18729224 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.18327823 |
| 35 | MP0005375_adipose_tissue_phenotype | 1.17283920 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.14963270 |
| 37 | MP0002822_catalepsy | 1.10765724 |
| 38 | MP0001661_extended_life_span | 1.09538337 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.08598070 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.07182309 |
| 41 | MP0005266_abnormal_metabolism | 1.04935433 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 0.98620243 |
| 43 | MP0002234_abnormal_pharynx_morphology | 0.90741291 |
| 44 | MP0008775_abnormal_heart_ventricle | 0.88537056 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 0.87822674 |
| 46 | MP0005275_abnormal_skin_tensile | 0.86710914 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 0.77046592 |
| 48 | MP0000003_abnormal_adipose_tissue | 0.72943088 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 0.72801796 |
| 50 | MP0004134_abnormal_chest_morphology | 0.70909395 |
| 51 | MP0006138_congestive_heart_failure | 0.70364099 |
| 52 | MP0005670_abnormal_white_adipose | 0.69703417 |
| 53 | MP0004043_abnormal_pH_regulation | 0.68007596 |
| 54 | MP0000343_altered_response_to | 0.67177856 |
| 55 | MP0004147_increased_porphyrin_level | 0.65588236 |
| 56 | MP0008961_abnormal_basal_metabolism | 0.64160263 |
| 57 | MP0000762_abnormal_tongue_morphology | 0.63349818 |
| 58 | MP0001299_abnormal_eye_distance/ | 0.63264199 |
| 59 | MP0003879_abnormal_hair_cell | 0.61911906 |
| 60 | MP0000266_abnormal_heart_morphology | 0.61734238 |
| 61 | MP0005334_abnormal_fat_pad | 0.61115037 |
| 62 | MP0000372_irregular_coat_pigmentation | 0.60504187 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 0.60462133 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 0.60421042 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 0.59386050 |
| 66 | MP0003828_pulmonary_edema | 0.55344181 |
| 67 | MP0004510_myositis | 0.52587496 |
| 68 | MP0004085_abnormal_heartbeat | 0.50263953 |
| 69 | MP0003045_fibrosis | 0.49040734 |
| 70 | MP0010030_abnormal_orbit_morphology | 0.48680727 |
| 71 | MP0005452_abnormal_adipose_tissue | 0.43059991 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41960039 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.41536050 |
| 74 | MP0008569_lethality_at_weaning | 0.39768169 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.38887769 |
| 76 | MP0003567_abnormal_fetal_cardiomyocyte | 0.38772276 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.38744523 |
| 78 | MP0000579_abnormal_nail_morphology | 0.38016555 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 0.37511977 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.35821787 |
| 81 | MP0005083_abnormal_biliary_tract | 0.35014062 |
| 82 | MP0003959_abnormal_lean_body | 0.34956821 |
| 83 | MP0001346_abnormal_lacrimal_gland | 0.34081909 |
| 84 | MP0002796_impaired_skin_barrier | 0.33129820 |
| 85 | MP0009672_abnormal_birth_weight | 0.32039355 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.31810758 |
| 87 | MP0009115_abnormal_fat_cell | 0.31490519 |
| 88 | MP0005451_abnormal_body_composition | 0.30580219 |
| 89 | MP0003948_abnormal_gas_homeostasis | 0.30349194 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 0.29970909 |
| 91 | MP0005535_abnormal_body_temperature | 0.28066697 |
| 92 | MP0002128_abnormal_blood_circulation | 0.28010909 |
| 93 | MP0001849_ear_inflammation | 0.27657571 |
| 94 | MP0005332_abnormal_amino_acid | 0.27063194 |
| 95 | MP0002114_abnormal_axial_skeleton | 0.26589259 |
| 96 | MP0005423_abnormal_somatic_nervous | 0.25992169 |
| 97 | MP0004142_abnormal_muscle_tone | 0.24778230 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.24287439 |
| 99 | MP0001853_heart_inflammation | 0.24128646 |
| 100 | MP0005165_increased_susceptibility_to | 0.23813739 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.22713990 |
| 102 | MP0003195_calcinosis | 0.21862737 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 0.21742229 |
| 104 | MP0001243_abnormal_dermal_layer | 0.20616941 |
| 105 | MP0005503_abnormal_tendon_morphology | 0.20251848 |
| 106 | MP0005187_abnormal_penis_morphology | 0.20151766 |
| 107 | MP0005166_decreased_susceptibility_to | 0.20032295 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.19702231 |
| 109 | MP0000383_abnormal_hair_follicle | 0.18114899 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.17469868 |
| 111 | MP0008770_decreased_survivor_rate | 0.17254490 |
| 112 | MP0001943_abnormal_respiration | 0.17117981 |
| 113 | MP0002067_abnormal_sensory_capabilities | 0.15219608 |
| 114 | MP0002249_abnormal_larynx_morphology | 0.15193988 |
| 115 | MP0006276_abnormal_autonomic_nervous | 0.15152604 |
| 116 | MP0002970_abnormal_white_adipose | 0.15057208 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.14819146 |
| 118 | MP0009697_abnormal_copulation | 0.13333554 |
| 119 | MP0004858_abnormal_nervous_system | 0.13159375 |
| 120 | MP0004924_abnormal_behavior | 0.13044679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 9.77089229 |
| 2 | * Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.26349966 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.76954847 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 8.08917699 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 7.87050437 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.49949500 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.04740508 |
| 8 | Myopathic facies (HP:0002058) | 6.79116472 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 6.43855085 |
| 10 | Round ear (HP:0100830) | 6.03936023 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.85608407 |
| 12 | Difficulty running (HP:0009046) | 5.47624357 |
| 13 | Myoglobinuria (HP:0002913) | 5.33364595 |
| 14 | Calcaneovalgus deformity (HP:0001848) | 5.09064634 |
| 15 | Absent phalangeal crease (HP:0006109) | 4.72685992 |
| 16 | Deformed tarsal bones (HP:0008119) | 4.66534463 |
| 17 | Increased connective tissue (HP:0009025) | 4.55644884 |
| 18 | Abnormality of the calf musculature (HP:0001430) | 4.48574311 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.43216082 |
| 20 | * EMG: myopathic abnormalities (HP:0003458) | 4.24969472 |
| 21 | Myotonia (HP:0002486) | 4.18934266 |
| 22 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.08245874 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 3.94943486 |
| 24 | * Hyporeflexia of lower limbs (HP:0002600) | 3.93327587 |
| 25 | * Muscle stiffness (HP:0003552) | 3.88049557 |
| 26 | Subaortic stenosis (HP:0001682) | 3.82479974 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.82479974 |
| 28 | * Muscle fiber splitting (HP:0003555) | 3.75369401 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.64437022 |
| 30 | Frequent falls (HP:0002359) | 3.45155242 |
| 31 | Difficulty climbing stairs (HP:0003551) | 3.44008763 |
| 32 | Malignant hyperthermia (HP:0002047) | 3.33399394 |
| 33 | Sudden death (HP:0001699) | 3.24689809 |
| 34 | * Neck muscle weakness (HP:0000467) | 3.20114521 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.17391434 |
| 36 | Abnormality of the calcaneus (HP:0008364) | 3.02964461 |
| 37 | Hyperkalemia (HP:0002153) | 2.94765620 |
| 38 | Slender build (HP:0001533) | 2.76750890 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.75997526 |
| 40 | EMG: neuropathic changes (HP:0003445) | 2.67188704 |
| 41 | Fatigable weakness (HP:0003473) | 2.57568231 |
| 42 | Abnormality of the neuromuscular junction (HP:0003398) | 2.57568231 |
| 43 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.52926246 |
| 44 | Paralysis (HP:0003470) | 2.44878221 |
| 45 | Generalized muscle weakness (HP:0003324) | 2.41843014 |
| 46 | Proximal amyotrophy (HP:0007126) | 2.41361338 |
| 47 | Facial diplegia (HP:0001349) | 2.41130691 |
| 48 | Ventricular tachycardia (HP:0004756) | 2.40145061 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.38048722 |
| 50 | Bulbar palsy (HP:0001283) | 2.35438365 |
| 51 | Spinal rigidity (HP:0003306) | 2.33996773 |
| 52 | Hypoplastic ischia (HP:0003175) | 2.30759741 |
| 53 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.27770816 |
| 54 | * Areflexia of lower limbs (HP:0002522) | 2.27225444 |
| 55 | Scapular winging (HP:0003691) | 2.24538351 |
| 56 | Gowers sign (HP:0003391) | 2.23770324 |
| 57 | Distal lower limb amyotrophy (HP:0008944) | 2.23740600 |
| 58 | * Rimmed vacuoles (HP:0003805) | 2.23508086 |
| 59 | Popliteal pterygium (HP:0009756) | 2.21054708 |
| 60 | Limb-girdle muscle atrophy (HP:0003797) | 2.17639852 |
| 61 | Weak cry (HP:0001612) | 2.10251835 |
| 62 | Nonprogressive disorder (HP:0003680) | 2.08169804 |
| 63 | Ulnar deviation of finger (HP:0009465) | 2.03614402 |
| 64 | Type 2 muscle fiber atrophy (HP:0003554) | 2.01647593 |
| 65 | Abnormality of the ischium (HP:0003174) | 2.01470768 |
| 66 | Metatarsus adductus (HP:0001840) | 2.00564111 |
| 67 | * Muscle fiber inclusion bodies (HP:0100299) | 10.0224190 |
| 68 | Lipoatrophy (HP:0100578) | 1.97095711 |
| 69 | Hip contracture (HP:0003273) | 1.96279692 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.95781085 |
| 71 | * Muscular dystrophy (HP:0003560) | 1.92552399 |
| 72 | Heart block (HP:0012722) | 1.89807046 |
| 73 | Dilated cardiomyopathy (HP:0001644) | 1.89362926 |
| 74 | Long clavicles (HP:0000890) | 1.86395522 |
| 75 | Muscle fiber atrophy (HP:0100295) | 1.84583129 |
| 76 | Fetal akinesia sequence (HP:0001989) | 1.82863251 |
| 77 | Abnormal atrioventricular conduction (HP:0005150) | 1.78204688 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 1.73949452 |
| 79 | Lower limb amyotrophy (HP:0007210) | 1.66060384 |
| 80 | Bundle branch block (HP:0011710) | 1.65698965 |
| 81 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 1.64667200 |
| 82 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.63985485 |
| 83 | Cholelithiasis (HP:0001081) | 1.63644333 |
| 84 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.61910602 |
| 85 | Amniotic constriction ring (HP:0009775) | 1.60684532 |
| 86 | Abnormality of placental membranes (HP:0011409) | 1.60684532 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 1.58670804 |
| 88 | Exercise intolerance (HP:0003546) | 1.57734528 |
| 89 | Tarsal synostosis (HP:0008368) | 1.57173112 |
| 90 | Ventricular arrhythmia (HP:0004308) | 1.56976088 |
| 91 | Increased intramyocellular lipid droplets (HP:0012240) | 1.56269608 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 1.54268483 |
| 93 | Increased purine levels (HP:0004368) | 1.54250235 |
| 94 | Hyperuricemia (HP:0002149) | 1.54250235 |
| 95 | Steppage gait (HP:0003376) | 1.53569796 |
| 96 | Abnormality of the foot musculature (HP:0001436) | 1.52832947 |
| 97 | Limited hip movement (HP:0008800) | 1.49772266 |
| 98 | Abnormality of potassium homeostasis (HP:0011042) | 1.49326010 |
| 99 | * Waddling gait (HP:0002515) | 1.48506323 |
| 100 | Short palpebral fissure (HP:0012745) | 1.47871669 |
| 101 | Increased muscle lipid content (HP:0009058) | 1.47268600 |
| 102 | * Limb-girdle muscle weakness (HP:0003325) | 1.46779807 |
| 103 | Stridor (HP:0010307) | 1.45720111 |
| 104 | Congenital hip dislocation (HP:0001374) | 1.45277215 |
| 105 | Adducted thumb (HP:0001181) | 1.45272715 |
| 106 | Palpitations (HP:0001962) | 1.44750982 |
| 107 | Easy fatigability (HP:0003388) | 1.43754104 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 1.43520771 |
| 109 | * Abnormality of the hip-girdle musculature (HP:0001445) | 1.43511074 |
| 110 | * Abnormality of the musculature of the pelvis (HP:0001469) | 1.43511074 |
| 111 | Gout (HP:0001997) | 1.42430645 |
| 112 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.41443647 |
| 113 | Synostosis involving bones of the feet (HP:0009140) | 1.41443647 |
| 114 | Toxemia of pregnancy (HP:0100603) | 1.38568416 |
| 115 | Oligomenorrhea (HP:0000876) | 1.37843180 |
| 116 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.30322886 |
| 117 | Diaphragmatic weakness (HP:0009113) | 1.25746883 |
| 118 | Neonatal hypotonia (HP:0001319) | 1.17237073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 9.55832495 |
| 2 | TTN | 6.37194404 |
| 3 | PHKG1 | 5.08419551 |
| 4 | PHKG2 | 5.08419551 |
| 5 | NME1 | 3.86691499 |
| 6 | PIK3CG | 3.71550584 |
| 7 | MAP2K3 | 2.65316993 |
| 8 | NEK1 | 2.27168302 |
| 9 | PINK1 | 2.14797981 |
| 10 | PDK3 | 2.13665861 |
| 11 | PDK4 | 2.13665861 |
| 12 | DMPK | 2.01161631 |
| 13 | MAP3K7 | 2.00847476 |
| 14 | TRIB3 | 1.84934421 |
| 15 | MUSK | 1.63493559 |
| 16 | BCKDK | 1.61345950 |
| 17 | MAPK12 | 1.55218639 |
| 18 | PIK3CA | 1.50457317 |
| 19 | MAP2K4 | 1.41809625 |
| 20 | PDK2 | 1.38667153 |
| 21 | MAP2K6 | 1.24083963 |
| 22 | CCNB1 | 1.07523090 |
| 23 | MAP3K3 | 0.98286980 |
| 24 | MARK1 | 0.95743749 |
| 25 | PKN2 | 0.91627558 |
| 26 | MAP3K13 | 0.88382917 |
| 27 | MAPKAPK3 | 0.84528385 |
| 28 | PRKAA2 | 0.83801505 |
| 29 | NEK9 | 0.81882122 |
| 30 | PRKAA1 | 0.80265080 |
| 31 | AKT2 | 0.68271990 |
| 32 | ZAK | 0.65281259 |
| 33 | ERBB3 | 0.63927132 |
| 34 | TRPM7 | 0.63906675 |
| 35 | STK24 | 0.62809468 |
| 36 | TAOK2 | 0.62386433 |
| 37 | MAPK11 | 0.57740237 |
| 38 | CAMK4 | 0.57464675 |
| 39 | CAMK2G | 0.54794241 |
| 40 | MAP3K11 | 0.54022376 |
| 41 | TAOK1 | 0.52057591 |
| 42 | RIPK1 | 0.50824584 |
| 43 | EPHB1 | 0.50768181 |
| 44 | TIE1 | 0.44768146 |
| 45 | ILK | 0.44375510 |
| 46 | SIK1 | 0.43976402 |
| 47 | CAMK1 | 0.40951999 |
| 48 | CAMK2B | 0.40913584 |
| 49 | PTK6 | 0.40497302 |
| 50 | ARAF | 0.39337120 |
| 51 | LIMK1 | 0.36470294 |
| 52 | MAP3K6 | 0.36380413 |
| 53 | PKN1 | 0.36059664 |
| 54 | SGK2 | 0.34910952 |
| 55 | MAP3K5 | 0.32313018 |
| 56 | RPS6KB1 | 0.31567179 |
| 57 | SGK1 | 0.30316960 |
| 58 | ROCK1 | 0.29487021 |
| 59 | MARK3 | 0.29262588 |
| 60 | TBK1 | 0.28624165 |
| 61 | PRKACB | 0.28457283 |
| 62 | MAPK13 | 0.28046496 |
| 63 | PRKD1 | 0.27629569 |
| 64 | INSRR | 0.27056836 |
| 65 | PRKG1 | 0.25750955 |
| 66 | EEF2K | 0.25247870 |
| 67 | TGFBR2 | 0.25115313 |
| 68 | MAP3K1 | 0.23082856 |
| 69 | RPS6KA3 | 0.21907829 |
| 70 | CAMK2D | 0.21611166 |
| 71 | RPS6KB2 | 0.20460545 |
| 72 | PRKACA | 0.20152670 |
| 73 | DAPK2 | 0.20029388 |
| 74 | MAP3K9 | 0.19879210 |
| 75 | MAPK4 | 0.19336984 |
| 76 | KSR2 | 0.17860833 |
| 77 | PDPK1 | 0.17764563 |
| 78 | SGK494 | 0.16714273 |
| 79 | SGK223 | 0.16714273 |
| 80 | MAPK7 | 0.16609833 |
| 81 | CDK19 | 0.15063506 |
| 82 | MARK2 | 0.14666269 |
| 83 | RAF1 | 0.14328674 |
| 84 | PDK1 | 0.14075599 |
| 85 | LATS1 | 0.13492899 |
| 86 | MAP2K1 | 0.12666132 |
| 87 | LATS2 | 0.11439090 |
| 88 | PRKG2 | 0.10468952 |
| 89 | ICK | 0.10384425 |
| 90 | PRPF4B | 0.10316881 |
| 91 | BRAF | 0.09668262 |
| 92 | MOS | 0.09372587 |
| 93 | MAP3K10 | 0.09034897 |
| 94 | PAK6 | 0.08728083 |
| 95 | RPS6KC1 | 0.08658338 |
| 96 | RPS6KL1 | 0.08658338 |
| 97 | TYK2 | 0.08576102 |
| 98 | FLT3 | 0.08273973 |
| 99 | RPS6KA1 | 0.08177086 |
| 100 | PRKACG | 0.07907529 |
| 101 | ZAP70 | 0.07515192 |
| 102 | DYRK1B | 0.06911873 |
| 103 | ERN1 | 0.06884642 |
| 104 | GSK3A | 0.06506535 |
| 105 | KSR1 | 0.06361100 |
| 106 | NLK | 0.06058287 |
| 107 | CAMK1G | 0.05726352 |
| 108 | RPS6KA6 | 0.05429316 |
| 109 | BMX | 0.05242984 |
| 110 | LMTK2 | 0.05148700 |
| 111 | STK11 | 0.04919963 |
| 112 | ROCK2 | 0.04849278 |
| 113 | SGK3 | 0.04377141 |
| 114 | MTOR | 0.04208795 |
| 115 | CAMK2A | 0.04183853 |
| 116 | JAK2 | 0.04060091 |
| 117 | LRRK2 | 0.04034284 |
| 118 | FER | 0.03462621 |
| 119 | PDGFRA | 0.03228510 |
| 120 | PTK2B | 0.02741065 |
| 121 | FGFR1 | 0.02545841 |
| 122 | GSK3B | 0.01942463 |
| 123 | MAPK8 | 0.01410384 |
| 124 | CSNK1D | 0.01159334 |
| 125 | MAPK10 | 0.01125281 |
| 126 | MAP3K4 | -0.0352018 |
| 127 | MAPK9 | -0.0301226 |
| 128 | FGFR3 | -0.0238026 |
| 129 | STK38 | -0.0105975 |
| 130 | RET | -0.0017315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.77923972 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.14922608 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.86515073 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.63590072 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.51610875 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.47376126 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.73553527 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.72499562 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.53822455 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.28009373 |
| 11 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.15483853 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.12076638 |
| 13 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.09948507 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.94250309 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.93165359 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.92112967 |
| 17 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.92054319 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.86875794 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.84890414 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79879178 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77308162 |
| 22 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72932907 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.64216299 |
| 24 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.61824310 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.55755031 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54939290 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.53683075 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53333191 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.49665442 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37517332 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27634067 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26312441 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.25179450 |
| 34 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.19841384 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19276408 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18693090 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14531170 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.12180722 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01025602 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99513373 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 0.92266480 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89374226 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.86385424 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83150018 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81562832 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81520099 |
| 47 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79705303 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77119569 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76373011 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76263773 |
| 51 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74034364 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71186568 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67536606 |
| 54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66514619 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63863141 |
| 56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63461142 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61372319 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.61064853 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59656988 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57275741 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54353076 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50675164 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.48994171 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45081375 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.44575591 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38701056 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.38651740 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.36914035 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36651478 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36301653 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35166313 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.33808648 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33012324 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30994059 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30196465 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28451125 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.28403924 |
| 78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.26641979 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25947645 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.24619459 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22373485 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21468371 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.21370977 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20142861 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.19645765 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.19536064 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.19203863 |
| 88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.18907158 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17764451 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17215228 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16980410 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15956344 |
| 93 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.15209990 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14546692 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14218848 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.13782649 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12731763 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12456952 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12156870 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.11448647 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.10962057 |
| 102 | Melanogenesis_Homo sapiens_hsa04916 | 0.10908335 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.10378632 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09591821 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.09423525 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08983163 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08681351 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.08276563 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07938622 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.07462430 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.06239040 |
| 112 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.05903214 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.05250241 |
| 114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05110168 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.05000102 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03706179 |

